Quality of life in patients with craniocervical dystonia

Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)"

Margherita Fabbri, Maria Superbo, Giovanni Defazio, Cesa Lorella Maria Scaglione, Elena Antelmi, Giacomo Basini, Stefania Nassetti, Fabio Pizza, Rosaria Plasmati, Rocco Liguori

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales "The Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)" were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.

Original languageEnglish
Pages (from-to)1053-1058
Number of pages6
JournalNeurological Sciences
Volume35
Issue number7
DOIs
Publication statusPublished - 2014

Fingerprint

Torticollis
Dystonia
Quality of Life
Botulinum Toxins
Surveys and Questionnaires
Health Surveys
Self Concept
Comorbidity
Clinical Trials
Control Groups
Population

Keywords

  • CDIP-58
  • CDQ-24
  • Craniocervical dystonia
  • Quality of life

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology
  • Medicine(all)

Cite this

Quality of life in patients with craniocervical dystonia : Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)". / Fabbri, Margherita; Superbo, Maria; Defazio, Giovanni; Scaglione, Cesa Lorella Maria; Antelmi, Elena; Basini, Giacomo; Nassetti, Stefania; Pizza, Fabio; Plasmati, Rosaria; Liguori, Rocco.

In: Neurological Sciences, Vol. 35, No. 7, 2014, p. 1053-1058.

Research output: Contribution to journalArticle

@article{390f42ecf5f44d93a40c0b2e70feb2be,
title = "Quality of life in patients with craniocervical dystonia: Italian validation of the {"}Cervical Dystonia Impact Profile (CDIP-58){"} and the {"}Craniocervical Dystonia Questionnaire (CDQ-24){"}",
abstract = "Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales {"}The Cervical Dystonia Impact Profile (CDIP-58){"} and the {"}Craniocervical Dystonia Questionnaire (CDQ-24){"} were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.",
keywords = "CDIP-58, CDQ-24, Craniocervical dystonia, Quality of life",
author = "Margherita Fabbri and Maria Superbo and Giovanni Defazio and Scaglione, {Cesa Lorella Maria} and Elena Antelmi and Giacomo Basini and Stefania Nassetti and Fabio Pizza and Rosaria Plasmati and Rocco Liguori",
year = "2014",
doi = "10.1007/s10072-014-1642-7",
language = "English",
volume = "35",
pages = "1053--1058",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "7",

}

TY - JOUR

T1 - Quality of life in patients with craniocervical dystonia

T2 - Italian validation of the "Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)"

AU - Fabbri, Margherita

AU - Superbo, Maria

AU - Defazio, Giovanni

AU - Scaglione, Cesa Lorella Maria

AU - Antelmi, Elena

AU - Basini, Giacomo

AU - Nassetti, Stefania

AU - Pizza, Fabio

AU - Plasmati, Rosaria

AU - Liguori, Rocco

PY - 2014

Y1 - 2014

N2 - Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales "The Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)" were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.

AB - Dystonia is a disabling and disfiguring disorder that can often affect many aspects of patients' daily lives, and lower their self-esteem. To date, quality of life (QoL) has been assessed in dystonic patients using generic measures that do not address the specific problems of this diagnostic group. Recently, two disease-specific scales "The Cervical Dystonia Impact Profile (CDIP-58)" and the "Craniocervical Dystonia Questionnaire (CDQ-24)" were validated for measuring QoL in craniocervical dystonia patients. No disease-specific scales for QoL for dystonic patients are currently available in Italian. The aim of our study was to produce and validate the Italian version of the CDIP-58 and CDQ-24. We obtained the Italian version of CDQ-24 and CDIP-58 with a back-translation design. Both scales were applied to a population of 94 craniocervical dystonia patients along with the Short Form 36 health-survey questionnaire (SF-36), both before and 4 weeks after botulinum toxin therapy. A group of 65 controls matched for sex, age and comorbidity underwent the SF-36. Internal consistency was satisfactory for all subscales. Both the CDIP-58 and CDQ-24 showed moderate to high correlations with similar items of the SF-36. Sensitivity to change was confirmed by highly significant improvements in all CDQ-24 subscales and by moderate improvements in three out of eight CDIP-58 subscales and total score. This is the first Italian study on QoL in dystonia patients. We validated the Italian version of two disease-specific questionnaires to evaluate QoL in craniocervical dystonia patients. These scales could be useful for both clinical practice and clinical trials.

KW - CDIP-58

KW - CDQ-24

KW - Craniocervical dystonia

KW - Quality of life

UR - http://www.scopus.com/inward/record.url?scp=84903385387&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903385387&partnerID=8YFLogxK

U2 - 10.1007/s10072-014-1642-7

DO - 10.1007/s10072-014-1642-7

M3 - Article

VL - 35

SP - 1053

EP - 1058

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 7

ER -